INTERDISCIPLINARY TRAINING IN CHILDHOOD CANCER RESEARCH

儿科肿瘤学在多学科领域处于领先地位。 病人护理，多机构合作。和跨学科临床 研究，以及基础和临床研究的整合。 在这一方向上继续取得进展正变得更具挑战性，因为 临床和生物研究的复杂性增加，随着 合作学科变得更加专业化。至关重要的是，我们 从不同的医学角度培训对儿童癌症感兴趣的研究人员 临床和生物研究方面的专业。分部 费城儿童医院(CHOP)的肿瘤学有很多 受欢迎的，董事会认证的儿科三年制课程 血液-肿瘤学奖学金培训，50%的研究员 花在临床或基础研究上的时间。这个项目有 自1985年以来培训了16名研究员，其中14名为全职学术人员 从事临床和/或实验室研究的职位。分部 及其在CHOP的附属机构，宾夕法尼亚大学和 Wistar研究所在临床和基础领域具有很强的领导力 科学研究。我们建议在这里培训精选的儿科肿瘤学 基础和临床研究方面的研究员，通过增加足够的支持 他们有时间获得研究金，以便完成这两个领域的项目。 我们还建议为住院医生和研究员提供研究培训 来自神经学、放射肿瘤学、外科和其他专业，谁 目前很少或没有更长的机会进行癌症 研究。所提供的支持将使我们能够减少财政支出 现在阻止许多受训人员获得高级 研究训练。通过这个节目，我们将训练下一个 一代临床癌症研究人员，他们的工作是将基础 科学研究临床问题将推动抗癌进展 在未来几十年里，所有年龄段的人都会这样做。

Pediatric oncology has a record of leadership in multidisciplinary patient care, multi-institutional. and interdisciplinary clinical research, and the integration of basic and clinical investigation. Continued progress in this direction is becoming more challenging, as the sophistication of clinical and biological research increases, and as cooperating disciplines become more specialized. It is essential that we train investigators interested in childhood cancer from different medical specialties in both clinical and biological research. The Division of Oncology of The Children's Hospital of Philadelphia (CHOP) has a much sought-after, board-certified three-year program of pediatric hematology-oncology fellowship training, with 50% percent of the fellows' time spent in either clinical or basic research. This program has trained 16 fellows since 1985, of whom 14 are in full-time academic positions conducting clinical and/or laboratory research. The Division and its affiliates at CHOP, the University of Pennsylvania, and the Wistar Institute have a strong record of leadership in clinical and basic science research. We propose here to train selected pediatric oncology fellows in both basic and clinical research, by adding enough supported time to their fellowships to allow completion of projects in both areas. We also propose to provide research training to residents and fellows from neurology, radiation oncology, surgery, and other specialties, who currently have few or no extended opportunities to conduct cancer research. The support provided would permit us to reduce the financial deterrents which now prevent many trainees from obtaining advanced research training. Through this program, we will train the next generation of clinical cancer researchers, whose work in bringing basic science to bear on clinical problems will advance progress against cancer in all age groups in the decades ahead.